Looks like you’re on the UK site. Choose another location to see content specific to your location
Mars Rebrands Linnaeus to AniCura at 200+ UK, Ireland Vet Sites
Mars Veterinary Health is rebranding Linnaeus as AniCura across more than 200 UK and Ireland veterinary practices and hospitals, consolidating its British and Irish network under the European AniCura identity. Announced on 19 November 2026 to coincide with the London Vet Show, the phased rollout aligns UK and Ireland sites with AniCura’s existing European footprint and formalises cross-border clinical collaboration already running inside the Mars veterinary group.
The rebrand affects practices and hospitals currently operating under the Linnaeus name, consolidating them into a single corporate identity across UK, Irish and European networks. Anna Cassell-Ward, UK and Ireland vice president at AniCura, said the company’s focus “remains exactly the same: delivering exceptional care for pets.” Nic Woodbridge, UK and Ireland medical director, added that adopting the AniCura name “provides a common identity that reflects those connections.” Leadership confirmed service standards and referral relationships will not change through the transition, and the phased rollout schedule has not been detailed publicly.
The commercial logic is European operational alignment. A single brand across UK, Ireland and continental practices simplifies cross-border clinical governance, procurement standardisation, referral pathways and professional development programmes. For the 200-plus UK and Ireland sites, the switch collapses parallel marketing, branding and website infrastructure into a single European platform. The timing is notable: UK corporate veterinary practice consolidation is under ongoing CMA market scrutiny, and a unified European brand positions Mars Veterinary Health’s UK operations within a wider international context rather than solely as a UK market participant.
The commercial signal is a maturing European corporate veterinary group operating model, where single-brand alignment across national markets unlocks shared infrastructure, procurement and clinical governance. Rollout pace and client retention through the brand transition remain critical near-term milestones. Expect further corporate veterinary brand consolidation across UK and European markets through 2027, particularly as CMA scrutiny shapes commercial positioning.
For the latest updates and in-depth insights into the world of Animal Health, including breakthrough treatments, industry trends, and regulatory news, contact Luca Sedicina today!
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard